PURPOSE: To evaluate the evolution of glycemic levels in newborns of hypertensive mothers according to maternal treatment. METHODS: Prospective randomized study, including 93 newborns of mothers treated with isradipine (n = 39), atenolol (n = 40), or low sodium diet (control group - n=14). Glycemia was determined at birth (mother and newborn by the oxidase glucose method) and in the 1st, 3rd, 6th, 12th, and 24th hours after birth (newborn by a test strip method). The evolution of glycemia was analyzed in each group (Friedman test). The groups were compared regarding glycemia (Kruskall-Wallis test), and linear regression models were constructed for the analyses (independent variable = maternal glycemia; dependent variables = umbilical cord, 3rd, and 6th hour glycemia). RESULTS: There were no statistically significant differences among the mean blood glucose levels of the 3 groups in any of the assessments. There was a correlation between maternal and umbilical cord blood glucose in the isradipine (r = 0.61; P
CITATION STYLE
Darcie, S., Leone, C. R., Calil, V. M. L. T., Prescinotti, E. P., Kahhale, S., & Zugaib, M. (2004). Glycemia in newborns of hypertensive mothers according to maternal treatment. Revista Do Hospital Das Clínicas, 59(5), 244–250. https://doi.org/10.1590/s0041-87812004000500004
Mendeley helps you to discover research relevant for your work.